Huang Zhanqin, Shi Ganggang, Gao Fenfei, Zhang Yanmei, Liu Xingping, Christopher Theodore A, Lopez Bernard, Ma Xinliang
Department of Pharmacology, Shantou University Medical College, Xinling Road 22, Shantou 515041, China.
Biochem Cell Biol. 2007 Apr;85(2):182-8. doi: 10.1139/O07-012.
The ability of N-n-butyl haloperidol iodide (F2) to cause vasodilation, and thereby produce a cardioprotective effect, has been well documented. The aim of this study was to investigate whether F2 might act as a Ca2+ antagonist. Myocytes were obtained from rat heart, and the whole-cell patch-clamp technique was used to record Ca2+ current. Laser scanning confocal microscopy was used to measure intracellular free calcium ([Ca2+]i). The results obtained from this study demonstrate that F2 reduced calcium current (ICa) in a concentration-dependent manner with an IC50 of 1.19 micromol/L, upshifted the current-voltage curve of ICa, shifted the inactivation kinetics of ICa leftward, and slowed down the recovery of ICa from inactivation. F2 decreased the fluorescent intensity of [Ca2+]i elevation induced by KCl with an IC50 of 1.61 micromol/L, and had no effects on the intracellular calcium release induced by caffeine and inositol-1,4,5-trisphosphate. These findings indicate that F2 may act as a calcium antagonist, which could account for its cardiovascular benefits.
碘化N-正丁基氟哌啶醇(F2)具有引起血管舒张从而产生心脏保护作用的能力,这一点已有充分记录。本研究的目的是调查F2是否可能作为一种Ca2+拮抗剂发挥作用。从大鼠心脏获取心肌细胞,并采用全细胞膜片钳技术记录Ca2+电流。利用激光扫描共聚焦显微镜测量细胞内游离钙([Ca2+]i)。本研究获得的结果表明,F2以浓度依赖的方式降低钙电流(ICa),IC50为1.19微摩尔/升,使ICa的电流-电压曲线向上移位,将ICa的失活动力学向左移位,并减缓ICa从失活状态的恢复。F2降低了由KCl诱导的[Ca2+]i升高的荧光强度,IC50为1.61微摩尔/升,并且对咖啡因和肌醇-1,4,5-三磷酸诱导的细胞内钙释放没有影响。这些发现表明,F2可能作为一种钙拮抗剂发挥作用,这可以解释其对心血管系统的益处。